Endoscopic Submucosal Dissection/ESD Market worth US$0.75 billion by 2030 with 8.4% CAGR | MarketsandMarkets™

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=116451960 Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=116451960 Browse in-depth TOC on "Endoscopic Submucosal Dissection Market" 197 - Tables 57 - Figures 234 - Pages By product,the endoscopic submucosal dissection (ESD) market is categorized based on product types into gastroscopes & endoscopes, knives, injection agents, tissue retractors,...
Comunicato Precedente

next
Comunicato Successivo

next

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=116451960

Browse in-depth TOC on "Endoscopic Submucosal Dissection Market"

197 - Tables
57 - Figures
234 - Pages

By product, the endoscopic submucosal dissection (ESD) market is categorized based on product types into gastroscopes & endoscopes, knives, injection agents, tissue retractors, grasp/clips, and other products. In 2024, the gastroscopes & endoscopes segment held the largest share of the global ESD market. The integration of AI-based detection and classification algorithms into endoscope platforms enhances the real-time identification of submucosal lesions, which increases the value of gastroscopes in ESD procedures and drives demand for this segment.

By Indication, The ESD market has been categorized into three segments based on indication: stomach cancer, colon cancer, and esophageal cancer. In 2024, stomach cancer accounted for the largest share of the ESD market. This is because the stomach offers a relatively wide and accessible area for ESD procedures, with fewer anatomical constraints than the esophagus or colon. As a result, the success and safety of procedures are higher, which contributes to the growth of the market.

By geography, in 2024, the Asia Pacific region held the largest share of the endoscopic submucosal dissection (ESD) market. This growth can be attributed to the rapid expansion of ambulatory surgical centers (ASCs), which prefer disposable instruments for their efficiency and speed, thus increasing demand. Additionally, numerous international fellowships and training centers in the Asia Pacific, particularly in Japan and South Korea, are producing a significant number of highly skilled ESD practitioners, which further drives the adoption of these procedures.

Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=116451960

The key players in the endoscopic submucosal dissection market include Olympus Corporation (Japan), FUJIFILM Holdings Corporation (Japan), Medtronic (Ireland), Boston Scientific Corporation (US), Sumitomo Bakelite Co., Ltd. (Japan), Creo Medical Group Plc (UK), HOYA Corporation (Japan), ConMed Corporation (US), STERIS (Ireland), MTW Endoskopie Manufaktur (Germany), Ovesco Endoscopy AG (Germany), Zeon Medical Inc. (Japan), Micro-Tech Endoscopy (China), Karl Storz SE & Co. KG (Germany), and Cook Medical (US), among others. These companies have implemented various growth strategies, including product launches, acquisitions, and expansions, to enhance their market presence and reach in the endoscopic submucosal dissection sector.

Olympus Corporation (Japan):

Olympus Corporation is a leading player in the endoscopic submucosal dissection market. The company's broad and comprehensive product portfolio related to endoscopy equipment is one of its key strengths. Olympus offers a variety of electrosurgical knives for endoscopic submucosal dissection procedures, including the DualKnife, FlexKnife, and HookKnife. The company invests a significant portion of its revenue in research and development to launch technologically advanced products. In 2024, Olympus's total R&D expenditure was USD 687.1 million, an increase from USD 616.1 million in 2023.

FUJIFILM Holdings Corporation (Japan)

FUJIFILM Holdings Corporation is a well-established brand in the endoscopic submucosal dissection market, with operations spanning worldwide. It offers a diverse range of endoscopic devices used for examinations related to esophageal, colorectal, and gastric cancer. The main end users of these products include hospitals, medical facilities, and research organizations. The company aims to maintain its brand value by expanding its geographic presence and promoting technological advancements, ensuring it remains a reliable provider of high-quality products.

Medtronic (Ireland)

Medtronic is a medical technology company that manufactures, designs, develops, and markets a broad range of solutions and medical devices for treating cardiac, spinal, neurological, vascular, and chronic conditions. The company also offers endoscopy products through its Respiratory, Gastrointestinal, and Renal business segment, which focuses on creating physician- and patient-centric solutions. Medtronic operates in over 150 countries worldwide.

For more information, Inquire Now!

Related Reports:

Endoscopic Submucosal Dissection/ESD Market worth US$0.75 billion by 2030 with 8.4% CAGR | MarketsandMarkets™

Endoscopy Equipment Market

Endoscope Reprocessing Market

Laparoscopic Instruments Market

Minimally Invasive Surgical Instruments Market

Single Use Surgical Instruments Market  

Get access to the latest updates on Endoscopic Submucosal Dissection Companies and Endoscopic Submucosal Dissection Market Size

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/endoscopic-submucosal-dissectionesd-market-worth-us0-75-billion-by-2030-with-8-4-cagr--marketsandmarkets-302538809.html

Ufficio Stampa

 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom

Allegati
Slide ShowSlide Show
Non disponibili
;